Status:
COMPLETED
The Effect of Remote Ischemic Preconditioning in Living Donor Hepatectomy
Lead Sponsor:
Asan Medical Center
Conditions:
Tissue Donors
Liver Transplantation
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Liver transplantation is the gold standard treatment for patients with end-stage liver disease. Despite its outstanding success, liver transplantation still entails certain complications including isc...
Detailed Description
Liver transplantation(LT) is the gold standard treatment for patients with end-stage liver disease. In light of advancements in surgical techniques, immunosuppressive agents, and perioperative critica...
Eligibility Criteria
Inclusion
- Donors who plan to have living right hepatectomy for liver transplantation.
- age : between 18 to 60 years.
Exclusion
- donors who plan to donate left lobe
- donors who plan to have laparoscopic right hepatectomy
- donors who cannot proceed remote ischemic preconditioning
Key Trial Info
Start Date :
August 22 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2017
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT03386435
Start Date
August 22 2016
End Date
October 30 2017
Last Update
August 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan medical center
Seoul, Songpa-gu, South Korea, 05505